1CL Deckers, SJ Czuczwar, YA Hekster, et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed [J]. Epilepsia,2000,41 (10) :1364 - 1374
2E Koekelmann, CE Elger, C Helmstaedter, et al. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antlepileptie drug polytherapy: relationships to blood serum levels and eomedieation [J]. Epilepsy & Behavior,2004,5(5) :716 - 721
3MA Werza, MR Sehoenberg, KJ Meador, et al. Subjective preference for lamotrigine of topiramate in healthy volunteers: Relationship to cognitive and behavioral functioning [ J ]. Epilepsy & Behavior, 2006,8 ( 1 ) : 181- 191
4JR Gates. Side effect profiles and behavioral consequences of antiepileptic medications[J] .Epilepsy & Behavior,2000,1(3):153 - 159
5C Glier, M Dzietko, P Bittigau. Therapeutic doses of topiramate are not toxic to the developing rat brain [ J ]. Exp Neurol, 2004,187 (2) : 403 - 405
6AP Aldenkamp, G Baker, OG Mulder. Effects of topiramate on cognition [J]. Neurol Neurosurg Psychiatry, 2001,71 (3) : 134 - 135
7M Castel-Braneo, VL Amilcar, Falcao, et al. Relationship between plasma and brain levels and the anticonvulsant effect of lamotrigine in rats[ J]. European Journal of Pharmacohigy,2003,482( 1 - 3) : 163-168
8AP Aldenkamy, MD Krom. Newer antiepileptie drug and cognitive issue [J] .Epilepsia,2003,44(4) :21 - 29
9McDonalda, Najama. The use of lamotrigine, vigabatfin and gabapentin as add-on therapy in intractable epilepsy of childhood [ J]. Seizure, 2005, 14 (2):112- 116
1[1]Aldenkamp AP, Baker GA, Meador KJ. The neuropsychology of epilepsy: What are the factors involved [ J ] . Epilepsy Behav, 2004, 5(1):s1 ～s2.
2[2]Beenen LF, Lindeboom J, Kasteleijn-Nolst, et al. Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability,and cognitive effects [J] . J Neurol Neurosurg Psychiatry, 1999,67(4): 474 ～ 80.
3[3]Pelrukhin AS, Mukhin Klu. Depakene ( sodium valproate)in the treatment of epilepsy in children and adolescents: efficiency and safety[J]. Zh Nevorl Psikhiatr Im S S Korsakova,2001,101 (6):20～7.
4[4]Chen Y, Chi Chow J, Lee Ⅰ.Comparison the cognitive effect of antiepileptic drugs in seizure-free children with epilepsy before and after drug withdrawal [ J ]. Epilepsy Res, 2001,44 ( 1 ): 65 ～ 70.
5[5]Kanner AM, Wuu J, Faught E, et al . A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events[J]. Epilepsy Behav,2003,4(5) :548 ～ 52.
6[6]Tatum Ⅳ WO,French JA, Faught E,et al. Postmarketing Experiance with Topiramate and Cognition[J]. E, pilepsia,2001, 42(9):1134～40.
7[7]Batea E, Santana Ⅰ, Castro G, et al. Cognitive effacts of therapy with topiramate in patients with refractory partial epilepsy [ J ]. Rev Neurol, 2002,34 (8): 737 ～ 41.
8[8]Lee S, Sziklas Ⅴ, Andermann F, et A1. The effects of adjunctive topiramate on cognitive function in patients with epilepsy [ J ] .Epilepsia, 2003,44 (3): 339 ～ 47.
9[9]Meador KJ, Loring DW, Hulihan JF, et al. Differential cognitive and behavioral effects of topiramate and valproate [ J ]. Neurology,2003,60(9): 1483 ～ 8.
10[10]Kockelmann E, Elger CE, Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of Topiramate in epilepsy patients [ J ] . Epilepsy Res,2003,54(2): 171 ～ 8.
